Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Belgian Body Warns Over Price Erosion

More Than 3,000 Off-Patent Drugs Set For Price Cuts From April

Executive Summary

With well over 3,000 off-patent medicines set for a price cut from the start of April in Belgium, local industry association Medaxes has voiced its support for government-led healthcare cost efficiencies but has warned of the risks of driving players out of the market with unsustainably low prices.

You may also be interested in...



Belgian Initiative Raises Awareness

Belgium’s Medaxes off-patent industry association has run a Generic Medicines Day to raise public awareness of the benefits of generics, as well as the obstacles that the industry faces.

Greater Uptake Must Become Belgium’s ‘New Normal’

Increased uptake for generics and biosimilars must become Belgium’s “new normal” in the wake of the coronavirus crisis, local off-patent industry association Medaxes has argued.

Belgian Body Welcomes Clawback Exemption Amid Price Cuts

Belgian body Medaxes is content with the latest pharmaceutical pricing legislation in the country, which cuts generics and biosimilars prices but also exempts such drugs from pharmaceutical clawback taxes.

Topics

UsernamePublicRestriction

Register

GB150797

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel